Join Now

Author Archives: admin

Myriad Genetics and Onsite Women’s Health Partner to Help More Women Understand Breast Cancer Risk

New collaboration increases access to genetic testing and can help identify patients with a high-risk for breast cancer SALT LAKE CITY, Aug. 22, 2023 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and Onsite Women’s Health, a leading national provider of breast health services, today announced the […]

Posted in BioUtah News | Comments Off on Myriad Genetics and Onsite Women’s Health Partner to Help More Women Understand Breast Cancer Risk

Government Price Setting Would Lead to Lost Therapies, Innovation and Jobs in Utah

New Study Details Proposed Federal Government-Mandated Drug Pricing Policies Senate SMART Prices Act Will Cost More Than 235 Fewer FDA Approvals Up To 23,000 Lost Jobs in Utah in Coming Decade SALT LAKE CITY, July 27, 2023 – Proposed expansions of federal government-mandated drug pricing policies present serious consequences for the development of and investment in […]

Posted in BioUtah News | Comments Off on Government Price Setting Would Lead to Lost Therapies, Innovation and Jobs in Utah

Recursion Launches Valence Labs at ICML with a Commitment to Open Science Including $1 Million in Academic Scholarships

Valence Labs is Recursion’s new machine learning research center that aims to promote open science and academic research. $1 million will be committed to advancing the next generation of academic machine learning research through scholarships and fellowships.SALT LAKE CITY, July 26, 2023 (GLOBE NEWSWIRE) — Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding […]

Posted in BioUtah News | Comments Off on Recursion Launches Valence Labs at ICML with a Commitment to Open Science Including $1 Million in Academic Scholarships

DEVICE FOR TREATING CHALLENGING BONE FRACTURES CLEARED BY FDA

A new system for fixing bone fractures, called the Bone Bolt System, has been approved for market by the U.S. Food and Drug Administration (FDA), the University of Utah Orthopaedic Innovation Center (OIC), Department of Orthopaedics and Spencer Fox Eccles School of Medicine announced on July 20, 2023. “This achievement demonstrates the commitment by the […]

Posted in BioUtah News | Comments Off on DEVICE FOR TREATING CHALLENGING BONE FRACTURES CLEARED BY FDA

Owlet Appoints Executive Jonathan Harris as New Company President and Chief Revenue Officer

LEHI, Utah–(BUSINESS WIRE)– Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), a pioneer of smart baby monitoring, today announces the appointment of executive Jonathan Harris as its new President and Chief Revenue Officer. Harris joins Owlet at a pivotal time in its business – one month after receiving clearance from the U.S. Food and Drug […]

Posted in BioUtah News | Comments Off on Owlet Appoints Executive Jonathan Harris as New Company President and Chief Revenue Officer

Bloom Surgical Awarded Competitive Grant from the NSF

Funding accelerates development of device for resolving visual disruptions in robotic procedures Salt Lake City, UT, June 1, 2023 – Bloom Surgical, Inc., a Utah-based surgical device startup, has been awarded a U.S. National Science Foundation Small Business Innovation Research grant for $256,000 to conduct research and development work on a novel micro-mechanical wiping mechanism […]

Posted in Policy News | Comments Off on Bloom Surgical Awarded Competitive Grant from the NSF

Rep. Moore Calls For Increased Transparency in the NCD Process

Utah U.S. Rep. Blake Moore (R-UT) signed onto a letter to HHS/CMS, led by House Ways and Means Committee Chair Jason Smith (R-MO) and House Energy and Commerce Committee Chair Kathy McMorris-Rodgers (R-WA), calling for increaed transparency in the NCD process following the agency’s recent release of the TCET notice. In part, the letter states, […]

Posted in Policy News | Comments Off on Rep. Moore Calls For Increased Transparency in the NCD Process

Owlet Appoints Healthcare Executive Melissa Gonzales to Board of Directors

LEHI, Utah–(BUSINESS WIRE)– Owlet, Inc. (NYSE: OWLT, “the Company”), the pioneer of smart baby monitoring, is pleased to announce the addition of Melissa Gonzales to the Company’s Board of Directors. Gonzales brings more than 20 years of consumer and provider healthcare experience to Owlet, further advancing the Company as a leader in infant monitoring solutions. […]

Posted in BioUtah News | Comments Off on Owlet Appoints Healthcare Executive Melissa Gonzales to Board of Directors

Co-Diagnostics, Inc. Awarded Funding for Co-Dx PCR Home Platform from NIH RADx® Tech Program

The Company intends to use the funds awarded by the National Institutes of Health for completion of its upper respiratory panel multiplex on Co-Dx PCR Home™ platform SALT LAKE CITY, July 13, 2023 /PRNewswire/ — Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company” or “Co-Dx”), a molecular diagnostics company with a unique, patented platform for the development […]

Posted in BioUtah News | Comments Off on Co-Diagnostics, Inc. Awarded Funding for Co-Dx PCR Home Platform from NIH RADx® Tech Program

Co-Diagnostics, Inc. Announces Recent Grant Awards

The Company intends to use funds awarded by the Bill & Melinda Gates Foundation toward completion of tuberculosis and HPV tests for its Co-Dx PCR Home™ platform  SALT LAKE CITY, July 18, 2023 /PRNewswire/ — Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company” or “Co-Dx”), a molecular diagnostics company with a unique, patented platform for the development of […]

Posted in BioUtah News | Comments Off on Co-Diagnostics, Inc. Announces Recent Grant Awards

ELEVAR THERAPEUTICS ANNOUNCES FDA ACCEPTANCE FOR FILING OF NEW DRUG APPLICATION FOR RIVOCERANIB IN COMBINATION WITH CAMRELIZUMAB AS A FIRST-LINE TREATMENT FOR UNRESECTABLE HEPATOCELLULAR CARCINOMA

FORT LEE, NEW JERSEY, July 17, 2023 – Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd. And a fully integrated biopharmaceutical company dedicated to elevating treatment experiences and outcomes for patients who have limited or inadequate therapeutic options, today announced that the U.S. Food and Drug Administration (FDA) accepted a new drug application […]

Posted in BioUtah News | Comments Off on ELEVAR THERAPEUTICS ANNOUNCES FDA ACCEPTANCE FOR FILING OF NEW DRUG APPLICATION FOR RIVOCERANIB IN COMBINATION WITH CAMRELIZUMAB AS A FIRST-LINE TREATMENT FOR UNRESECTABLE HEPATOCELLULAR CARCINOMA

Stuart Goldblatt Joins CenExel as CEO

Salt Lake City, July 17, 2023 /GlobeNewswire/ — The CenExel Board of Directors is delighted to announce that Stuart Goldblatt has joined CenExel as our new CEO effective July 17, 2023. Tom Wardle will transition to the role of Executive Chairman, CenExel Board of Directors. Said Tom Wardle, “We are very excited to have a […]

Posted in BioUtah News | Comments Off on Stuart Goldblatt Joins CenExel as CEO